Micardis and Tachypnea - a phase IV clinical study of FDA data
Summary:
Tachypnea is reported as a side effect among people who take Micardis (telmisartan), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Estradiol, and have Headache.
The phase IV clinical study analyzes which people have Tachypnea when taking Micardis. It is created by eHealthMe based on reports of 26,556 people who have side effects when taking Micardis from the FDA, and is updated regularly.
What is Micardis?
Micardis has active ingredients of telmisartan. It is often used in high blood pressure. eHealthMe is studying from 27,605 Micardis users. Check the latest studies of Micardis.
What is Tachypnea?
Tachypnea is found to be associated with 1,069 drugs and 1,936 conditions by eHealthMe. Check the latest studies of Tachypnea.
26,556 people reported to have side effects when taking Micardis.
Among them, 30 people (0.11%) have Tachypnea.

Among these 30 people:
How long have people been on Micardis when they have Tachypnea? *
- < 1 month: 50 %
- 1 - 6 months: 50 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Tachypnea when taking Micardis? *
- female: 66.67 %
- male: 33.33 %
What is the age of people who have Tachypnea when taking Micardis? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 15.79 %
- 50-59: 15.79 %
- 60+: 68.42 %
What are other drugs people take besides Micardis? *
- Bisoprolol Fumarate: 11 people, 36.67%
- Amoxicillin: 11 people, 36.67%
- Euthyrox: 11 people, 36.67%
- Estradiol: 11 people, 36.67%
- Botox: 7 people, 23.33%
- Mirtazapine: 4 people, 13.33%
- Maxair: 2 people, 6.67%
- Norethindrone And Ethinyl Estradiol: 2 people, 6.67%
- Norvasc: 2 people, 6.67%
- Nystatin: 2 people, 6.67%
What are other side effects people have besides Tachypnea? *
- Weakness: 14 people, 46.67%
- Malaise (a feeling of general discomfort or uneasiness): 14 people, 46.67%
- Fatigue (feeling of tiredness): 14 people, 46.67%
- Depression: 12 people, 40.00%
- Visual Impairment: 12 people, 40.00%
- Speech Disorder: 12 people, 40.00%
- Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking): 12 people, 40.00%
- Cough: 12 people, 40.00%
- Fall: 12 people, 40.00%
- Weight Increased: 12 people, 40.00%
What are the existing conditions these people have? *
- Birth Control: 11 people, 36.67%
- Headache (pain in head): 11 people, 36.67%
- Endometriosis (appearance of endometrial tissue outside the uterus and causing pelvic pain): 10 people, 33.33%
- Stress And Anxiety: 5 people, 16.67%
- Essential Hypertension (primary hypertension): 2 people, 6.67%
- Suicide Attempt: 2 people, 6.67%
- Gastrointestinal Disorder (functional problems of gastrointestinal tract): 1 person, 3.33%
- Colon Cancer: 1 person, 3.33%
- Constipation: 1 person, 3.33%
- Diabetes: 1 person, 3.33%
* Approximation only. Some reports may have incomplete information.
Do you take Micardis and have Tachypnea?
- Check whether Tachypnea is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Micardis:
- Micardis (27,605 reports)
Tachypnea treatments and more:
- Tachypnea (16,675 reports)
How severe was Tachypnea and when was it recovered:
Expand to all the drugs that have ingredients of telmisartan:
- Tachypnea and drugs with ingredients of telmisartan (40 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Micardis:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Tachypnea:
- Tachypnea (1,069 drugs)
Browse all the conditions that are associated with Tachypnea:
- Tachypnea (1,936 conditions)
Related publications that referenced our studies
- Kato Y, Mukai Y, Rane A, Inotsume N, Toda T, "The inhibitory effect of telmisartan on the metabolism of arachidonic acid by CYP2C9 and CYP2C8: an in vitro study", Biological and Pharmaceutical Bulletin, 2017 Sep .
- Kim HK, Youm JB, Lee SR, Lim SE, Lee SY, Ko TH, Nilius B, Noh JH, Ko KS, Rhee BD, Kim N, "The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action", Pflügers Archiv-European Journal of Physiology, 2012 Dec .
- Kato Y, Mukai Y, Rane A, Inotsume N, Toda T, "The inhibitory effect of telmisartan on the metabolism of arachidonic acid by CYP2C9 and CYP2C8: an in vitro study", Biological and Pharmaceutical Bulletin, 2017 Sep .
- Kim HK, Youm JB, Lee SR, Lim SE, Lee SY, Ko TH, Nilius B, Noh JH, Ko KS, Rhee BD, Kim N, "The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action", Pflügers Archiv-European Journal of Physiology, 2012 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on telmisartan (the active ingredients of Micardis) and Micardis (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Mercaptopurine cause Large Intestinal Ulcer? - 2 seconds ago
- Could Cinnamon cause Irritable Bowel Syndrome? - 4 seconds ago
- Could Victoza cause Abdominal Distension? - 4 seconds ago
- Drug interactions of Dorzolamide Hydrochloride and Ceftriaxone Sodium - 7 seconds ago
- Could Everolimus cause Rashes? - 7 seconds ago
- Ketoprofen vs. Darvon-N, side effect and effectiveness comparison - 8 seconds ago
- Ultracet vs. Piroxicam, side effect and effectiveness comparison - 9 seconds ago
- Could Altace cause Ocular Hyperaemia? - 9 seconds ago
- Could Nuvigil cause Fluid Retention? - 9 seconds ago
- Sulfadiazine vs. Calcium, side effect and effectiveness comparison - 10 seconds ago